Τόμος 18 (2004) – Τεύχος 3 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 18 (2004) – Issue 3 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Department of Midwifery, Technological Educational Institution of Athens, Athens, Greece

Accepted for publication: 1 September 2004

pharmakonpress[at]pharmakonpress[.]gr

2.    Twining P., McHugo J., Pilling D.: Textbook of Fetal Abnormalities. P. 346, Churchill Livingstone, London, 2000

3.    Sandikcioglu M., Moisted K., Kjaer I.: The prenatal development of the human nasal and vomeral bones. J. Craniol. Genet. Dev. Biol. 14: 124-134 (1994)

4.    Guis F., Ville Y., Vincent Y., Doumere S.: Ultrasound evaluation of the length of the fetal nasal bone throughout gestation. Ultrasound Obstet. Gynecol. 5: 304-307 (1995)

5.    Stempfle N., Huten Y., Fredouille C., et al.: Skeletal abnormalities in fetuses with Down syndrome: a radiographic post-mortem study. Pediatr. Radiol. 29: 682-688 (1999)

6.    Cicero S., Curcio P., Papageorgiou A., Sonek J., Nicolaides K.: Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 355: 1665-1667 (2001)

7.    Cicero S., Sonek J., McKemma D., Croom C., Johnson L., Nicolaides K.: Nasal bone hypoplasia in trisomy 21 at 15-22 weeks gestation. Ultrasound Obstet. Gynecol. 21: 15-18 (2002)

8.    Sonek J., Nicolaides K.: Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am. J. Obstet. Gynecol. 186: 139-141 (2002)

9.    Cicero S., Bindra Ft., Rembouskos G., Tripsanas C., Nicolaides K.H..:Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation. J. Matern. Fetal Neonatal. Med. 11: 400-402 (2002)

10.  Monni G., Zoppi M., Ibba R.: Absence of nasal bone and detection of trisomy 21. Lancet 359:1343 (2002)

11.  Bromley B., Lieberman E., Shipp T., Benaccerraf B.: Fetal nose bone length, a marker for Down syndrome in the second trimester. J. Ultrasound Med. 21: 1387-1394 (2002)

12.  Cicero S., Bindra R., Rembouskos G., Spenser K., Nicolaides K.: Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent nasal bone, free beta-h CG and PAPP-A at 11 to 14 weeks. Prenat. Diagn. 23: 306-310 (2003)

13.  Cicero S., Longo D., Rembouskos G., Sacchini C., Nicolaides K.: Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet. Gynecol. 22: 31-35 (2003)

14.  Orlandi F., Bilardo C., Campogrande M., Kranlz D., et al.: Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment. Ultrasound Obstet. Gynecol. 22: 36-39 (2003)

15.  Kanellopoulos V., Katsetos C., Economides D.: Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound Obstet. Gynecol. 22: 131-134 (2003)

16.  Vintzileos A., Walters C., Yeo L.: Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high risk population. Obstet. Gynecol. 101: 905-908 (2003)

17.  Lee W., DeVore GR., Comstock CH., et al.: Nasal bone evaluation in fetuses with Down syndrome during the second and third trimester of pregnancy. J. Ultrasound Med. 22: 55-60 (2003)

18.  Cicero S., Rembouskos G., Vandecruys H.. Hogg M., Nicolaides K.: Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14 weeks scan. Ultrasound Obstet. Gynecol. 23: 218-223 (2004)

19.  Prefumo F., Sairam S., Bhide A., Penna L., et al.: Maternal ethnic origin and fetal nasal bones at 11-14 weeks of gestation. Br. J. Obstet. Gynecol 111: 109-112 (2004)

20.  Chen M., Lee C., Leung K., et al.: Pilot study on the midsecond trimester examination of fetal nasal bone in the Chinese population. Prenatal Diagn. 24: 87-91 (2004)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr